Thromboembolic events during treatment with thalidomide

被引：60

作者：

Urbauer, E ^{[1
]}

Kaufmann, H ^{[1
]}

Nösslinger, T ^{[1
]}

Raderer, M ^{[1
]}

Drach, J ^{[1
]}

机构：

[1] Vienna Gen Hosp, Dept Internal Med 1, Clin Div Cardiol, A-1090 Vienna, Austria

来源：

BLOOD | 2002年 / 99卷 / 11期

关键词：

D O I：

10.1182/blood-2001-12-0245

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4247 / 4248

页数：2

共 5 条

[1] Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients [J].

Barlogie, B ;

Desikan, R ;

Eddlemon, P ;

Spencer, T ;

Zeldis, J ;

Munshi, N ;

Badros, A ;

Zangari, M ;

Anaissie, E ;

Epstein, J ;

Shaughnessy, J ;

Ayers, D ;

Spoon, D ;

Tricot, G .

BLOOD, 2001, 98 (02) :492-494

[2] Treatment of Waldenstrom's macroglobulinemia with thalidomide [J].

Dimopoulos, MA ;

Zomas, A ;

Viniou, NA ;

Grigoraki, V ;

Galani, E ;

Matsouka, C ;

Economou, O ;

Anagnostopoulos, N ;

Panayiotidis, P .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3596-3601

[3] Deep venous thrombosis and thalidomide therapy for multiple myeloma. [J].

Osman, K ;

Comenzo, R ;

Rajkumar, SV .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1951-1952

[4] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

[5] Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy [J].

Zangari, M ;

Anaissie, E ;

Barlogie, B ;

Badros, A ;

Desikan, R ;

Gopal, AV ;

Morris, C ;

Toor, A ;

Siegel, E ;

Fink, L ;

Tricot, G .

BLOOD, 2001, 98 (05) :1614-1615

← 1 →